enVVeno Medical Corporation(NVNO)

$10.75—Stale · unknown old

enVVeno Medical Corporation(NVNO)

NASDAQ • Last print unknown ago

$10.75—Stale · unknown old

NVNO(NVNO)

NVNO

Q4 2026 EPS Estimate

$-3.27

Oct 30, 2026

Revenue Estimate

$2M

No analyst ratings available

No analyst price targets available for NVNO

Analyst coverage may not be available for this symbol

Forward Growth Estimates (YoY)

FY2027

Rev+140.00%

EPS—

FY2028

Rev+70.95%

EPS—

FY2030

Rev-75.63%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2030E
Revenue Avg	$7M	$17M	$29M	$7M
Low	$7M	$17M	$29M	$7M
High	$7M	$17M	$29M	$7M
EBITDA Avg	$-9M	$-3M	$-2M	—
Low	$-9M	$-3M	$-2M	—
High	$-9M	$-3M	$-2M	—
EBIT Avg	$-10M	$-4M	$-2M	—
Low	$-10M	$-4M	$-2M	—
High	$-10M	$-4M	$-2M	—
Net Income Avg	$-10M	$-4M	$-2M	—
Low	$-10M	$-4M	$-2M	—
High	$-10M	$-4M	$-2M	—
EPS Avg	$-16.19	$-6.22	$-3.25	—
Low	$-16.19	$-6.22	$-3.25	—
High	$-16.19	$-6.22	$-3.25	—
Analysts (Rev / EPS)	1 / 1	1 / 1	1 / 1	1 / —

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028
Revenue Avg	$2M	$3M	$3M	$4M	$4M	$6M	$5M	$6M
Low	$2M	$3M	$3M	$4M	$4M	$6M	$5M	$6M
High	$2M	$3M	$3M	$4M	$4M	$6M	$5M	$6M
EBITDA Avg	$-2M	$-1M	$-1M	$-1M	$-895,219	$-752,157	$-575,315	$-498,909
Low	$-2M	$-1M	$-1M	$-1M	$-895,219	$-752,157	$-575,315	$-498,909
High	$-2M	$-1M	$-1M	$-1M	$-895,219	$-752,157	$-575,315	$-498,909
EBIT Avg	$-2M	$-2M	$-1M	$-1M	$-986,371	$-838,751	$-657,580	$-577,060
Low	$-2M	$-2M	$-1M	$-1M	$-986,371	$-838,751	$-657,580	$-577,060
High	$-2M	$-2M	$-1M	$-1M	$-986,371	$-838,751	$-657,580	$-577,060
Net Income Avg	$-2M	$-2M	$-1M	$-1M	$-986,371	$-838,751	$-657,580	$-577,060
Low	$-2M	$-2M	$-1M	$-1M	$-986,371	$-838,751	$-657,580	$-577,060
High	$-2M	$-2M	$-1M	$-1M	$-986,371	$-838,751	$-657,580	$-577,060
EPS Avg	$-3.27	$-2.35	$-1.86	$-1.64	$-1.47	$-1.25	$-0.98	$-0.86
Low	$-3.27	$-2.35	$-1.86	$-1.64	$-1.47	$-1.25	$-0.98	$-0.86
High	$-3.27	$-2.35	$-1.86	$-1.64	$-1.47	$-1.25	$-0.98	$-0.86
Analysts (Rev / EPS)	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1

No recent analyst actions

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance